Andrew Anzalone

Andrew Anzalone

Company: Prime Medicine

Job title: Head of Prime Editing Platforms


Exploring the Potential of Prime Editing 10:15 am

• Discuss prime editing systems for introducing precise genome edits, and their potential as therapeutics for addressing diverse genetic disorders • Examine data demonstrating the capability of prime editing systems to mediate both small and large deletions and insertions • Explore recent developments in prime editing systemsRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.